IDH.L Gross Margin

As of 2025-07-09, the Gross Margin of Immunodiagnostic Systems Holdings PLC (IDH.L) is 4967.6%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

IDH.L Gross Margin - Historical Value

Date	Value
2020-03-31	4967.6%
2019-03-31	43.4%
2018-03-31	47.5%
2017-03-31	49.8%
2016-03-31	58.6%
2015-03-31	62.5%
2014-03-31	74.5%
2013-03-31	73.1%
2012-03-31	74.7%
2011-03-31	74.7%

IDH.L Gross Margin - Peers Comparison

Ticker	Name	Value
ADDERA.ST	AdderaCare AB	28.4%
ADDV A.ST	ADDvise Group AB (publ)	39.9%
ALBLU.PA	Bluelinea SA	99.3%
ALCOR.PA	Biocorp Production SA	91.2%
ALSGD.PA	Spineguard SA	70.8%
ALSPW.PA	Spineway SA	70.7%
ALTER.PA	Theradiag SA	74.2%
ALVMG.PA	Klea Holding	94.2%
ARCOMA.ST	Arcoma AB	39.9%
BIOBV.HE	Biohit Oyj	65.3%
BOUL.ST	Boule Diagnostics AB	45.7%
CRAD B.ST	C Rad AB	47%
DGM.PA	Diagnostic Medical Systems SA	39.3%
DIGN.ST	Dignitana AB	67.1%
ELOS B.ST	Elos Medtech AB	34.9%
EOSI.PA	EOS Imaging SA	52.9%
GME.DE	Geratherm Medical AG	45.4%
IHC.L	Inspiration Healthcare Group PLC	42.8%
MDG.WA	Medicalgorithmics SA	84.9%
MEDIC.AT	Medicon Hellas SA	74.5%
MKEA.PA	Mauna Kea Technologies SAS	9.8%
NXTMH.HE	Nexstim Oyj	95.9%
OPTOMED.HE	Optomed Oyj	64.3%
SDI.L	SDI Group PLC	63.1%
SDOS.ST	ScandiDos AB	46.4%
STIL.ST	Stille AB	51.9%
STNT.PA	Stentys SA	40.6%
SUN.L	Surgical Innovations Group PLC	28.8%